← Open Payments lookup

DOREEN HUFFMAN: Open Payments

NPI 1043230170 · NEW BEDFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,005 in 95 payments from 13 companies in 2025. Trend: 2023 $2,049 · 2024 $1,330 · 2025 $2,005

Food & beverage: $2,005
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.15$508
Otsuka America Pharmaceutical, Inc.22$343
ABBVIE INC.19$333
Alkermes, Inc.13$224
Neurocrine BioSciences, Inc.6$122
Vanda Pharmaceuticals Inc.3$96
Teva Pharmaceuticals USA, Inc.3$79
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$67
Janssen Pharmaceuticals, Inc3$66
Axsome Therapeutics, Inc.3$64

Products named: COBENFY, VRAYLAR, REXULTI, ARISTADA, INGREZZA, FANAPT, VIVITROL, CAPLYTA.

Industry payments across MA — which companies pay providers there.